HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 21 to 40 of 52
< previous   next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleOmori, Kazuno; Nakamura, Akinobu; Miyoshi, Hideaki; Yamauchi, Yuki; Kawata, Shinichiro; Takahashi, Kiyohiko; Kitao, Naoyuki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, TatsuyaGlucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing beta-Cell Mass in db/db Mice-Diabetes-Apr-2021
articleOba‐Yamamoto, Chiho; Takeuchi, Jun; Nakamura, Akinobu; Takikawa, Ryoko; Ozaki, Ayano; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, HideakiCombination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia-Journal of Diabetes Investigation-Apr-2021
articleNomoto, Hiroshi; Oba-Yamamoto, Chiho; Takahashi, Yuka; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, HideakiEffects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes : Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)-Diabetes Therapy-Mar-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of Diabetes Investigation-Feb-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of diabetes investigation-Feb-2021
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] Relationships between clinically relevant factors and log-transformed LBGI, according to multiple regression analysis ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The calculated variance inflation factors ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The coefficient of variation distribution among the three C-peptide subgroups ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The scatter plot for coefficient of variation ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The scatter plot for low blood glucose index ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] Correlations in the items associated with coefficient of variation ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] Correlations between low blood glucose index and clinical factors ---22-Dec-2020
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study)-Diabetes, Obesity and Metabolism-Mar-2020
articleKameda, Reina; Nomoto, Hiroshi; Cho, Kyu Yong; Kawata, Shinichiro; Omori, Kazuno; Takeuchi, Jun; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, HideakiEffects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study-BMJ Open-Feb-2020
articleShibayama, Yui; Kameda, Hiraku; Ota, Shoichiro; Tsuchida, Kazuhisa; Cho, Kyu Yong; Nakamura, Akinobu; Miyoshi, Hideaki; Atsumi, TatsuyaCase of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab-Journal of diabetes investigation-Sep-2019
articleTakase, Takahiro; Nakamura, Akinobu; Yamamoto, Chiho; Nomoto, Hiroshi; Miya, Aika; Dannoura, Midori; Cho, Kyu Yong; Kurihara, Yoshio; Manda, Naoki; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiImprovement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes : A randomized controlled trial-Journal of Diabetes Investigation-May-2019
articleOmori, Kazuno; Nomoto, Hiroshi; Nakamura, Akinobu; Takase, Takahiro; Cho, Kyu Yong; Ono, Kota; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiReduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide : A randomized controlled trial of repaglinide vs sulfonylurea-Journal of Diabetes Investigation-Mar-2019
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiEffect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus : An open-label, prospective, randomized, parallel-group comparison trial-Diabetes, Obesity and Metabolism-Mar-2019
articleTakahashi, Kiyohiko; Cho, Kyu Yong; Nakamura, Akinobu; Miya, Aika; Miyoshi, Arina; Yamamoto, Chiho; Nomoto, Hiroshi; Niwa, Hirokatsu; Takahashi, Kiyohito; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Ito, Yoichi M; Atsumi, Tatsuya; Miyoshi, HideakiShould sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes-Journal of Diabetes Investigation-Mar-2019
articleCho, Kyu Yong; Nakamura, Akinobu; Oba-Yamamoto, Chiho; Tsuchida, Kazuhisa; Yanagiya, Shingo; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSwitching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus : Randomized Controlled Trial-Diabetes & Metabolism Journal-2019
Showing results 21 to 40 of 52
< previous   next >

 

Hokkaido University